Results 311 to 320 of about 119,881 (373)

Significance and challenges of immunopharmacogenomics. [PDF]

Front Immunol
Hanci Handzha L, Nakamura Y.
europepmc   +1 more source

Therapeutic Potential of CAR-CIK Cells in Acute Leukemia Relapsed Post Allogeneic Stem Cell Transplantation. [PDF]

Cancers (Basel)
Canichella M, de Fabritiis P, Abruzzese E.   +2 more
europepmc   +1 more source

Elevated high-density lipoprotein levels following acute graft-versus-host disease onset: a potential link to T-cell dysfunction and increased relapse risk. [PDF]

Clin Transl Immunology
Böttcher-Loschinski R, Karl F, Drettwan D, Wittmann J, Jacobs B, Völkl S, Bruns H, Mackensen A, Mougiakakos D.   +8 more
europepmc   +1 more source

Low- and high-dose post-transplant cyclophosphamide attenuates graft-versus-host disease with distinct effects on PD-1+ T cell subsets. [PDF]

Clin Sci (Lond)
Sligar C, Jacobs MJ, Elhage A, Sluyter R, Watson D.   +4 more
europepmc   +1 more source

Changes in Gut Phageome and Bacteriome Following Fecal Microbiota Transfer in Patients with Intestinal Graft-Versus-Host Disease and Crohn's Disease. [PDF]

Microorganisms
Chukhlovin AB, Goloshchapov OV, Shchukina OB, Kharitidis AM, Zhloba AA, Subbotina TF, Kusakin AV, Kosarev OV, Tsai VV, Kalinin RS, Eismont YA, Glotov OS.   +11 more
europepmc   +1 more source

Adeno-associated viral vectors encoding anti-P2X7 nanobodies reduce graft-versus-host disease in a humanised mouse model. [PDF]

Clin Transl Immunology
Elhage A, Hadaya JH, Sligar C, Watson D, Adriouch S, Sluyter R.   +5 more
europepmc   +1 more source

Micronutrient requirements for stem cell transplantation patients > 100 days after transplant and during graft versus host disease: a systematic review. [PDF]

Support Care Cancer
Johnson C, McCormack D, Brown T, MacLaughlin HL, Blake C, Willims R, Andersen S.   +6 more
europepmc   +1 more source

The lost chord: Microchimerism [PDF]

, 1996
Demetris, AJ, Murase, N, Rao, AS, Starzl, TE, Thomson, AW, Trucco, M   +5 more
core  

Development of a humanized mouse model of graft-versus-host disease to assess human regulatory T cell function. [PDF]

Front Immunol
Beguin C, Kwan O, Ehx G, Humblet-Baron S, Köse MC, Dubois S, Canti L, Courtois J, Daulne C, Caers J, Beguin Y, Ritacco C, Baron F.   +12 more
europepmc   +1 more source

T Cell immune reconstitution after allo-HSCT: key factors and implications. [PDF]

Blood Sci
Dai W, Dong F, Cheng T, Hao S.
europepmc   +1 more source